MannKind Corp. (MNKD)
3.305
+0.06
(+1.69%)
USD |
NASDAQ |
May 21, 16:00
3.305
0.00 (0.00%)
After-Hours: 19:59
MannKind Research and Development Expense (TTM) : 72.56M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| United Therapeutics Corp. | 539.20M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| BioMarin Pharmaceutical, Inc. | 721.03M |
| Geron Corp. | 73.59M |
| Insmed, Inc. | 828.00M |